26 results
424B5
INM
InMed Pharmaceuticals Inc
3 Jun 22
Prospectus supplement for primary offering
9:45pm
, enforcing, defending and protecting our intellectual property;
our ability to hire additional clinical, quality control, sales and scientific personnel
424B3
INM
InMed Pharmaceuticals Inc
7 Apr 22
Prospectus supplement
4:46pm
products and/or technologies;
maintaining, expanding, enforcing, defending and protecting our intellectual property;
our ability to hire additional
DEF 14A
uga75c7i606rq45o2
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
iw0d4ap2kg4 rw8
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
xjutxemyt5yxkzk g1h
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
kws9ou0b z95k5sq2zq5
24 Sep 21
Annual report
7:31am
424B3
l1v pumqg2
22 Jul 21
Prospectus supplement
10:27am
424B3
a0ktwhjb5iidi aog
16 Mar 21
Prospectus supplement
12:00am
10-Q
iqpgauerxlt38z
17 Dec 20
Quarterly report
12:00am
424B4
xav5c5qp3
13 Nov 20
Prospectus supplement with pricing info
8:52pm